Fig. 1 · Structure
Documents & Downloads
IK-862
TACE Inhibitor
IK-862 is a selective inhibitor of Tumor Necrosis Factor-alpha Converting Enzyme (TACE), which plays a critical role in the release of pro-inflammatory cytokines. As a TACE inhibitor, IK-862 exhibits key biological activity by reducing tumor progression and inflammation, making it valuable in cancer and inflammatory disease research. This compound can be utilized in studies focused on understanding the role of TACE in various pathological processes and therapeutic interventions targeting cytokine regulation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 478911-60-3 |
| Applications | TACE Inhibitor |
| Formula | C25H27N3O4 |
| Molecular Weight | 433.50 |
| SMILES | C[C@]1(C2=CC=C(C=C2)OCC3=CC(C)=NC4=C3C=CC=C4)C(N(CC1)[C@H](C)C(NO)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.